HuagongsheHuagongshe Chemistry Print Report · For research reference only
Hydrogen Bromide → Darifenacin
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Hydrogen Bromide | HCID 260 | — |
| Reactant | 1-Butanol | HCID 263 | — |
| Reactant | 2-{1-[2-(Benzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamide | HCID 19746803 | — |
| Catalyst | Palladium | HCID 23938 | — |
| Solvent | Acetic Acid | HCID 176 | — |
| Product | Darifenacin | HCID 444031 | 85% |
Reaction Steps
Pd/C 10% (0.8 g) was added to a solution of S)-2-{1-[2-(benzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamide (8 g) in acetic acid (160 ml). The mixture was hydrogenated at 45-50° C. and at atmospheric pressure for about 6-7 hrs. Catalyst was filtered off and solution was concentrated under vacuum obtaining an oily residue. n-Butanol (40 ml) was added and stirred to obtain a solution. 48% HBr (3.5 g) was added and a mixture n-Butanol/water was eliminated by distillation to reduce water content to less then 1%. Darifenacin .HBr crystallizes and after 2 hrs at 15-20° C. was filtered and washed with n-Butanol (3×5 ml). After drying at 55-60° C. under vacuum 8.1 g of Darifenacin hydrobromide were obtained. (Yield 85%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07442806B2 |
| Source dataset | uspto-grants-2008_10 |
| ORD ID | ord-c42a57a650104b7e8b1a47eb557fc1ea |
| Source note | uspto-grants-2008_10 |